Marina Provides Initial Data on miRNA Mimetic Knockdown, Touts Breadth of Growing Delivery Portfolio

At the Rodman & Renshaw Healthcare Conference in New York this Week, a company official noted that in work conducted with Mirna Therapeutics, Marina found a 100-fold increase in microRNA in three different tissues, along with downregulation of the intended gene targets.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.